Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,676 | Dovepress* | 14,045+ | 1,156 | 15,201 | |
| PubMed Central* | 1,631 | 564 | 2,195 | ||
| Totals | 15,676 | 1,720 | 17,396 | ||
| *Since 8 June 2018 | |||||
View citations on PubMed Central and Google Scholar